Log in to save to my catalogue

Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabil...

Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabil...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1928783065

Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT–mTORC1 activation

About this item

Full title

Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT–mTORC1 activation

Publisher

New York: Nature Publishing Group US

Journal title

Nature medicine, 2017-09, Vol.23 (9), p.1055-1062

Language

English

Formats

Publication information

Publisher

New York: Nature Publishing Group US

Subjects

Subjects and topics

More information

Scope and Contents

Contents

Mutations in
SPOP
, the gene encoding a component of the E3 ubiquitin ligase complex, impair ubiquitination-dependent degradation of BRD2, BRD3 and BRD4 proteins and result in activation of ATK–mTORC1 signaling and resistance to BET inhibitors. Pharmacological blockade of AKT represents a viable strategy to restore the sensitivity of SPOP-mut...

Alternative Titles

Full title

Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT–mTORC1 activation

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_1928783065

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1928783065

Other Identifiers

ISSN

1078-8956

E-ISSN

1546-170X

DOI

10.1038/nm.4379

How to access this item